Laxmi Organic Industries’ board approved the re-appointment of Dr. Rajiv Banavali as an Independent Director for a second term, subject to shareholder approval. The board also reviewed and approved the unaudited standalone and consolidated financial results for Q3 2026, showing revenue from operations at ₹7,068.72 million. The results will be published in newspapers and are available on the company’s website and stock exchanges.
Independent Director Re-Appointment
The Board approved the re-appointment of Dr. Rajiv Banavali as an Independent Director for a second term of two years, effective from May 18, 2026, to May 17, 2028. This re-appointment is subject to the approval of the shareholders. Dr. Banavali brings over 38 years of experience in the chemicals sector to the company.
Financial Performance for Q3 2026
The Board reviewed and approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Q3 2026).
Key Standalone Figures:
Revenue from operations stood at ₹7,068.72 million, compared to ₹7,678.72 million for the same quarter last year.
Total income was reported at ₹7,100.46 million.
Key Consolidated Figures:
Revenue from operations stood at ₹7,186.82 million compared to ₹7,863.35 million for the same quarter last year.
Additional Approvals
The board approved the issuance of a postal ballot notice to shareholders to seek approval for the re-appointment of Dr. Rajiv Banavali.
Source: BSE
